Moreover, by analyzing the TCGA database, we found that EphA2 is highly expressed and correlated with various clinicopathological parameters in ccRCC, including gender, T stage, G stage, and TNM stage (Table 2 and Supplementary Fig. 4a–h). This evidence concerns the gene EPHA2 and nonpapillary renal cell carcinoma.